BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24895507)

  • 1. Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.
    Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Lee CS; Kim JS
    Nucl Med Mol Imaging; 2013 Mar; 47(1):44-51. PubMed ID: 24895507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.
    Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Kim JS
    Clin Nucl Med; 2017 Feb; 42(2):e80-e87. PubMed ID: 27922865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
    Lee H; Sung YH; Hwang KH
    Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic accuracy of dual-phase
    Oh M; Lee N; Kim C; Son HJ; Sung C; Oh SJ; Lee SJ; Chung SJ; Lee CS; Kim JS
    Sci Rep; 2021 Jul; 11(1):14992. PubMed ID: 34294739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary Gland Uptake on
    Kang SY; Yun JY; Kang YK; Moon BS; Yoon HJ; Yoo MY; Kim BS
    Korean J Radiol; 2023 Jul; 24(7):690-697. PubMed ID: 37404111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CT.
    Park E; Hwang YM; Lee CN; Kim S; Oh SY; Kim YC; Choe JG; Park KW
    Nucl Med Mol Imaging; 2014 Jun; 48(2):106-13. PubMed ID: 24900150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
    Kaasinen V; Kankare T; Joutsa J; Vahlberg T
    J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrastriatal
    Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
    Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early perfusion and dopamine transporter imaging using
    Hong CM; Ryu HS; Ahn BC
    Am J Nucl Med Mol Imaging; 2018; 8(6):360-372. PubMed ID: 30697456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson's Disease Using Quantitative Indices of
    Cheon M; Kim SM; Ha SW; Kang MJ; Yang HE; Yoo J
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
    Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
    Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
    Nicastro N; Burkhard PR; Garibotto V
    J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
    Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
    Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.